209 related articles for article (PubMed ID: 32514245)
1. LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway.
Li Y; Ma HY; Hu XW; Qu YY; Wen X; Zhang Y; Xu QY
Cancer Cell Int; 2020; 20():200. PubMed ID: 32514245
[TBL] [Abstract][Full Text] [Related]
2. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
[TBL] [Abstract][Full Text] [Related]
3. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
7. LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells.
Zhang Q; Li X; Li X; Li X; Chen Z
J Cell Biochem; 2018 Jun; 119(6):4447-4457. PubMed ID: 29219208
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
[TBL] [Abstract][Full Text] [Related]
9. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
11. TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.
Ma HY; Li Y; Yin HZ; Yin H; Qu YY; Xu QY
Mol Ther Nucleic Acids; 2020 Dec; 22():640-656. PubMed ID: 33230463
[TBL] [Abstract][Full Text] [Related]
12. lncRNA H19 predicts poor prognosis in patients with melanoma and regulates cell growth, invasion, migration and epithelial-mesenchymal transition in melanoma cells.
Shi G; Li H; Gao F; Tan Q
Onco Targets Ther; 2018; 11():3583-3595. PubMed ID: 29950863
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer.
Si H; Chen P; Li H; Wang X
Am J Transl Res; 2019; 11(5):3213-3225. PubMed ID: 31217890
[TBL] [Abstract][Full Text] [Related]
14. LncRNA H19-Derived miR-675-3p Promotes Epithelial-Mesenchymal Transition and Stemness in Human Pancreatic Cancer Cells by targeting the STAT3 Pathway.
Wang F; Rong L; Zhang Z; Li M; Ma L; Ma Y; Xie X; Tian X; Yang Y
J Cancer; 2020; 11(16):4771-4782. PubMed ID: 32626524
[No Abstract] [Full Text] [Related]
15. H19 Knockdown Suppresses Proliferation and Induces Apoptosis by Regulating miR-130a-3p/SATB1 in Breast Cancer Cells.
Zhong G; Lin Y; Wang X; Wang K; Liu J; Wei W
Onco Targets Ther; 2020; 13():12501-12513. PubMed ID: 33324070
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
17. [Low expression of lncRNA-GAS5 promotes epithelial-mesenchymal transition of breast cancer cells in vitro].
Ding YX; Duan KC; Chen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1427-1435. PubMed ID: 29180320
[TBL] [Abstract][Full Text] [Related]
18. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract][Full Text] [Related]
19. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT.
Zhong M; Zhu M; Liu Y; Lin Y; Wang L; Ye Y; Chen H; Yang Y; Zhuang G; Huang J
J Cancer; 2020; 11(10):3061-3071. PubMed ID: 32226521
[No Abstract] [Full Text] [Related]
20. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
Zheng JF; Guo NH; Zi FM; Cheng J
Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
